tert-Butyl (2-((4-chlorobenzyl)amino)ethyl)carbamate, 95.0%, 1g

Sodium pentane-1-sulfonate hydrate, 95.0%, 10g

2-(4-methoxy-3-methylphenyl)acetyl chloride, 95.0%, 250mg

3-AMINO-5-BROMOPHENOL, 95.0%, 250mg

tert-Butyl (1R*,4R*)-4-(2-chlorobenzylamino)cyclohexylcarbamate, 1g

AZTAK1 INHIBITOR, 98.0%, 5mg

4-Nitro-1-n-phenylbenzene-1,2-diamine, 95+%, 100mg

2,2-Dimethylbenzo[d][1,3]dioxol-5-amine, 97%, 1g

6-Oxo-6-phenylhexanoic acid, 98.0%, 1g

2,5-Dibromofuran (stabilised with MgO), 95.0%, 1g

Sodium 1-Pentadecanesulfonate1g

3-Furan-2-yl-3-oxo-propionic acid ethyl ester, 95.0%, 10g

rEGCase I assisted by Activator II1vial